Objective: To develop and validate a score to predict postoperative acute renal failure (ARF) after liver resection. Background: Postoperative ARF after major surgery is associated with morbidity and mortality. Early identification of patients at risk of ARF is important in order to provide protective kidney treatment. Methods: Postoperative ARF was prospectively assessed in consecutive patients undergoing liver resection. In randomly selected two-third of the total number of patients, multivariate logistic regression analysis was used to develop a new prediction score (including a full and a reduced model), based on the preoperative parameters of age, gender, preexisting chronic renal dysfunction, cardiovascular disease, diabetes, bilirubin, and alanine aminotransferase (ALT) levels. In the remaining last third of the patients, the new score was validated by calibrating the accuracy of the score (ClinicalTrials.gov NCT 00743132). Results: Postoperative ARF occurred in 15.1% (86 of 569 consecutive patients) from 2002 to 2007 and was highly associated with mortality (22.5% vs. 0.8% without ARF, P Ͻ 0.001). In the 380 (two-third of the population) patients selected for the development of the prediction score, preoperatively elevated ALT, preexisting cardiovascular disease, chronic renal failure, and diabetes were the strongest predictors of ARF. Validating the full prediction model (0 -22 points) to the remaining 189 patients (one-third of the population), the risk could be predicted accurately (mean predicted risk of 11.5% vs. an observed risk of 14.8%) without significant differences between predicted and observed risks across different risk categories (P ϭ 0.98). Prediction with the reduced model including the 4 strongest predictors (0 -7 points) was almost as accurate as with the full model (11.4% predicted vs. 14.8% observed) and also without significant differences across different risk categories (P ϭ 0.75).
A cute renal failure (ARF) is a major complication after abdominal surgery, associated with substantial mortality, morbidity, and costs. [1] [2] [3] Reported incidences of postoperative ARF range from 1% after major noncardiac surgery without liver resection 3 to around 20% after cardiac surgery 4 -6 and up to 50% after liver transplantation. [7] [8] [9] [10] [11] [12] [13] The comparability of postoperative ARF across different studies is difficult due to a lack of standardized definition of ARF. Only very limited data exists regarding the occurrence of ARF in patients after liver resection, as well as its impact on outcome. 14 -17 It is essential to identify, ideally preoperatively, those patients at risk to develop ARF to perform prevention strategies for this population. Effective preventive modalities involve all related disciplines including surgery, anesthesia, and intensive care. Perioperative management to lower the risk of ARF could include fluid management, suspension of nephrotoxic drugs, and protective strategies for ischemic reperfusion injuries. 18 -20 There is currently no validated prediction score available to identify patients undergoing liver resection at risk for postoperative ARF. Kheterpal et al developed a prediction score for ARF after noncardiac surgery in patients with previous normal renal function 3 but they failed to validate the score system. Proper validation is indispensable before the routine use in clinical practice of any predictive score system. 21 Moreover, few studies identified risk factors for postoperative ARF in cardiac 22 and liver transplant patients, but without developing prediction rules. 8, 11, 13 Therefore, the aim of this study was to develop and validate a simple and readily applicable score based on preoperative parameters to predict postoperative ARF in patients scheduled for liver resection.
MATERIALS AND METHODS

Study Design, Population
We conducted a cohort study and included consecutive patients undergoing any type of liver resection between July 1, 2002 and October 31, 2007 in a single tertiary care center (Swiss Hepato-Pancreato-Biliary ͓HPB͔Center, University Hospital of Zurich, Switzerland). Patients with trauma of the liver were excluded. All data were collected using standardized forms and entered into the database of the Swiss HPB Center. The study was approved by the Institutional Review Board for human studies and internationally registered at clinicaltrials.gov (NCT 00743132).
Perioperative Management
The perioperative management in our HPB center was constant during the whole study period following modern guidelines in liver surgery. Intra-and early postoperative care was performed in a close collaboration of surgery with anesthesiology, intermediate and intensive care unit to offer an optimized treatment after surgery. A special attention was given to the fluid management with policy of low volume and low central venous pressure intraoperatively.
Definition of Postoperative ARF
Postoperative ARF was defined according to the RIFLE criteria as an absolute increase in serum-creatinine of more than 0.3 mg/dL above baseline, or an increase of more than 1.5 times the preoperative baseline value within 48 hours after surgery, or a reduction of urinary output less than 0.5 mL/kg/h for at least 6 hours. [23] [24] [25] [26] [27] A renal failure in context with a multiorgan failure occurring much later than 48 hours postoperatively was not defined as "postoperative ARF."
Selection of Predictors of ARF
To facilitate the future use and further validation of our prediction score, we only considered preoperative, reproducible, and readily available predictive parameters. We also decided a priori to restrict the number of potential predictors to less than 10 to increase the applicability of the score in practice and to reduce the risk of over-fitting that would threaten the accuracy of the prediction score in other populations.
Therefore, we considered the following predictors: age, gender, preexisting chronic renal failure, cardiovascular disease, diabetes as well as preoperative bilirubin and alanine aminotransferase (ALT) levels. We did not consider parameters like malignancy of liver disease, neoadjuvant chemotherapy, or whether patients had a primary and secondary liver tumor because they have not shown significant associations with ARF. 17,28 -30 Since, we considered only preoperative parameters to develop a risk score that support perioperative, decision-making for kidney-protective treatments, we excluded parameters that become available intra-or postoperatively (for eg, histologic features).
Chronic renal failure was defined as a glomerular filtration rate (GFR) of less than 60 mL/min/1.73 m 2 for all adults. 31, 32 Cardiovascular disease was defined as the presence of a coronary heart disease, previous coronary revascularization, cerebral arterial occlusive disease, and/or peripheral vascular occlusive disease.
Statistical Analysis
We followed the standard approach to develop a prediction score. 21, 33, 34 We first developed the multivariate model to predict ARF in a randomly selected two-thirds of our study population (so-called derivation population), and validated the model in the remaining third (validation population). For the random selection of patients for the derivation and validation population, we specified that the incidence of ARF should be comparable in both populations (defined as the incidence for the entire population). For the development of the prediction score in the derivation population, we developed a multivariate logistic regression model with ARF as the dependent and all 7 predictors as independent variables. We calculated the area under the curve to estimate how well the model discriminated between patients with and without ARF. To reduce the risk that the multivariate logistic regression model overestimated the associations of the 7 predictors with ARF (impairing the accuracy of the model for other populations), we used shrinkage. Shrinkage describes the use of a constant factor (for eg, 0.8) with which the regression coefficients of the 7 predictors are multiplied. The size of the shrinkage factor expresses the overoptimism of the multivariate model and depends on the goodness of fit of the multivariate logistic regression model and the number of predictors. 35 All prediction models must be validated in a new set of patients before use in practice 21, 33, 34 to ensure the predicted risks for an outcome provide an accurate and reliable basis for treatment decisions. The most important requirement for a prediction score is that the predicted risk for the outcome (for eg, a 20% risk of ARF in a specific patient) is as accurate as possible. For this purpose, we assessed the calibration of our multivariate logistic regression model. Calibration refers to the comparison of risks as predicted by the model with the actual observed risks. We assessed calibrationin-the-large, which is the comparison between the mean predicted risk for ARF in our validation population and the observed risk of ARF (proportion of patients with postoperative ARF). In addition, we compared predicted and observed risks for ARF within different risk classes (Ͼ0%-10%, Ͼ10%-20%, etc) and used the Hosmer-Lemeshow test to assess whether predicted and observed risks differed significantly from each other, which would indicate poor calibration.
Finally, we were interested in whether the inclusion of only the 4 strongest predictors instead of all predictors would still provide an accurate prediction model. Fewer variables would further increase the applicability of the prediction score in practice. To select the 4 strongest predictors, we used a stepwise backward logistic regression model that retained variables with an association of P Յ 0.3. 33 We used bootstrapping to repeat the selection process 380 times (size of derivation population) and chose those 4 variables that were selected most often. Bootstrapping is a method to validate the selection of variables within the same data set. We then repeated all the above analyses and compared discrimination (area under the curve) and calibration between the full model (7 predictors) and the reduced model (4 predictors).
Since the use of regression equations is hardly implementable in clinical practice, we developed a simple prediction score from the underlying regression equations following a standard approach. 36 Briefly, the regression coefficients are transformed into points so that they reflect the strengths of association. For eg, for a predictor that is weakly associated with the outcome, only 1 point is assigned, whereas a strong predictor receives 3 or more points. The points for each predictor are summed up and for each total score a specific risk for ARF is given. 
RESULTS
Study Population
A total of 576 consecutive patients were assessed for eligibility in our department. After exclusion of 7 trauma cases, 569 patients were finally included in the study ( Fig. 1 ). Mean age was 57.2 years (standard deviation ͓SD͔: 14.3), 12.8% had preexisting chronic renal disease, 74.9% suffered from malignant liver disease, of whom 49.3% received a preoperative chemotherapy ( Table 1) . Major liver resection was performed in 57.3% of patients, and the average duration of surgery was almost 5 hours ( Table 2 ).
Outcome Following Liver Resection
The incidence of postoperative ARF was 15.1% (86 of 569 patients) and overall mortality 4.2% (24 of 569 patients). Table 1 shows that patients with ARF were on average 10 years older (mean age: 65.1 years ͓SD: 11.3 years͔) than patients without ARF (55.8 years ͓14.4 years͔). Patients with ARF suffered more often from advanced steatosis (17.5% vs. 10.6%), were more frequent and the rate of major liver resection (67.4% vs. 55.5%, respectively) as well as blood loss was higher (mean blood loss: 768.1 ͓SD: 714.7 mL͔ vs. 508.0 mL ͓657.5 mL͔, respectively) in the ARF group compared with the non-ARF group. Patients with ARF were significantly more likely to die within 30 days (23.2%) compared with patients without ARF (0.8%, unadjusted odds ratio: 36.3 ͓95% CI: 12.0 -109.9͔, P Ͻ 0.001 and odds ratio: 22.5 ͓95% CI: 6.2-81.7͔, P Ͻ 0.001), when adjusted for age, gender, preexisting cardiovascular diseases, chronic obstructive pulmonary disease, diabetes, chronic renal failure, peak ALT, and malignancy of liver disease). Also, length of intensive care unit (ICU) (adjusted difference: 7.9 days ͓95% CI: 6.4 -9.3͔, P Ͻ 0.001) and hospital stay (adjusted difference: 9.5 days ͓95% CI: 6.7-12.4͔, P Ͻ 0.001) were also statistically significantly longer in patients with postoperative ARF compared with patients without ARF (Table 3) . Table 4 shows the outcome in patients with or without postoperative renal failure, including the cause of death. The progress of the postoperative ARF is demonstrated in Table 5 . In 26.7% of the patients with ARF a postoperative hemofiltration had to be performed and 5 of those 23 patients (21.7%) needed a persistent hemodialysis.
Development of the Prediction Model
Of the 380 patients (two-thirds) randomly selected for the development of the prediction model, 58 (15.3%) had postoperative ARF (Fig. 2) . Table 6 shows the multivariate model with the 7 predictors of ARF and the risk score. Elevated ALT levels (Ͼ35/50 U/L for women/men, respectively), showed the greatest association with postoperative ARF (odds ratio: 3.34) followed by preexisting cardiovascular disease (odds ratio: 3.29), preexisting chronic renal failure (3.08), and diabetes (2.34). The area under the curve was 0.80, which indicated good discrimination of patients with and without ARF by the combination of the 7 predictors. The point score ranges from 0 to 22 points (highest risk for ARF). For the 4 strongest predictors, 3 to 5 points are assigned when present, whereas for elevated bilirubin levels (Ն17 mol/L) and female gender, only one point is assigned.
Validation of the Prediction Model
The validation population comprised the remaining 189 patients ( Fig. 2) . Based on the multivariate model, the predicted mean risk for ARF was 11.5%, whereas the observed risk for ARF was 14.8% (28 of 189 patients). Thus, the overall predicted risk differed from the observed risk by only 3.3%. Predicted and observed were very similar across the entire range of risk for ARF, which was 
Development and Validation of the Reduced Prediction Model
We selected preexisting cardiovascular disease, elevated ALT levels (Ͼ35/50 U/L for women/men, respectively), preexisting chronic renal failure, and diabetes for the reduced prediction model, because they were selected most often as important predictors of ARF in the 380 repetitions of the backward logistic regression selection process (358 times for preexisting cardiovascular disease, 350 times for preexisting chronic renal failure, 339 times for diabetes, and 300 times for high ALT levels). Table 7 shows the development of the regression model and the prediction score. The area under the curve was 0.77, which was only slightly less than for the 7 predictors. The point score ranges from 0 to 7 points (highest risk for ARF).
The mean predicted risk was 11.4%, which was 3.4% below the observed risk (14.8%). The Hosmer-Lemeshow test confirmed that predicted and observed risks did not differ significantly across risk classes (P ϭ 0.75). Calibration of the reduced risk model was therefore nearly as good as for the full model with 7 predictors. Tables 6 and 7 show how many points are assigned if a risk factor is present. Finally, Table 8 shows the risk of ARF associated with each point increase for the full and reduced risk scores. For example, using the full score, a score of 7 is associated with a risk of 17.8%. The full score provides a wide range of risk prediction from 4.1% for 0 points to 87.3% for 22 points and a subtle differentiation of the risk for ARF. In turn, the reduced risk score ranges from 5.8% to 80.5% with larger intervals between risk scores.
Full and Reduced Risk Scores to Predict ARF After Liver Resection
DISCUSSION
We developed and validated an easily applicable score to predict the risk for ARF in patients scheduled for liver resection. Early identification of patients at high risk of ARF is important because, as our study showed, ARF is strongly associated with mortality and the need for extended ICU and hospital care. The score based on 7 parameters showed good discrimination and calibration. We also developed a reduced score based on the 4 strongest predictors such as preexisting cardiovascular disease, chronic renal failure, diabetes, and high levels of ALT, which predicted ARF nearly as accurately as the full score. Depending on the purpose, clinicians and investigators can choose between the full and the reduced risk scores. While the full score provides a more subtle prediction of the risk for ARF, the reduced score is simpler, and more likely to be used in clinical practice. Postoperative ARF is known to significantly impair the outcome after major surgery. 1, 3 However, the lack of a standard definition of postoperative ARF has hindered the comparability of published data. [23] [24] [25] [26] [27] Neither the incidence nor the clinical relevance (mortality, morbidity, and hospital stay) of postoperative ARF following liver surgery have been conclusively clarified. To our knowledge, the present study represents the largest series of patients focused on the evaluation of postoperative ARF following liver resection in a modern specialized center, and over a recent period of time. ARF was defined according the so called RIFLE criteria representing the internationally most accepted and validated criteria based on interdisciplinary, international consensus process carried out by Acute Dialysis Quality Initiative Workgroup. [23] [24] [25] 27 Postoperative ARF was documented in 15.1% of the patients following liver resection, and significantly correlated not only with an increased mortality compared with patients without postoperative ARF (23.2% vs. 0.8%, P Ͻ 0.001), but also with a prolonged length of hospital (adjusted difference: 9.5 days ͓95% CI: 6.7-12.4͔, P Ͻ 0.001) and ICU (adjusted difference: 7.9 days ͓95% CI: 6.4 -9.3͔, P Ͻ 0.001) stay. ARF was the main reason for death in more than half of the patients 12 who died, while the second most cause of death was infection (Table 4) .
A validated score as this one is of importance. From an academic perspective, it is a tool to stratify the risks of patient collectives within scientific projects. Moreover, it may directly impacts on future clinical practice. Risk scores combine information available at a moment where decisions might be taken and our score aims at a preoperative evaluation of the postoperative risk for ARF. This is of particular importance because kidney function can be influenced by several modifiable factors in the interdisciplinary perioperative management process (surgery, anesthesiology, and intensive care medicine). Therefore, the present score may support decision-making for kidney-protective interventions during the entire perioperative period, which may improve patient outcomes. Of note, intraoperative parameters, including histologic features such as steatosis or blood loss, can still be considered to update the preoperative risk prediction and to support decision-making for the postoperative management. For example, a patient might be at moderate risk preoperatively but have a much higher risk for ARF after suffering from substantial loss or after diagnosing severe steatosis. Such an updated risk score, however, would again need to be developed and validated.
Therapeutic options to prevent and to treat ARF following liver resection include pre-, intra-, and postoperative approaches. There are several possible targets for optimizing, treating, and influencing the postoperative renal function following liver resection as we will show in following passages.
A number of preoperative predictors have been identified in this present study. It is obvious that treatable and modifiable parameters such as cardiac dysfunction, preoperative kidney dysfunction, diabetes, and preoperative cholestasis should be optimized. Regarding intraoperative factors influencing the postoperative renal function, many parameters have been described. 16,17,28,38 -40 Blood loss and the extent of liver resection have been described as the most relevant risk factor for mortality and morbidity after hepatectomy. 17, 28 In this context, the role of low intraoperative central venous pressure (CVP) and fluid restriction, which is a modern and widely accepted strategy in many hepatobiliary centers may need to be adjusted according to the risk of developing postoperative renal failure. 16, 38, 39 Several studies have confirmed a reduced blood loss due to a low CVP (Ͻ5 mm Hg). 16, 38, 39 Of these, Melendez et al 16 demonstrated a rate of ARF of only 3.1%, while others 38, 39 showed higher rates of postoperative renal failure, dialysis requirement, and mortality with "too" low intraoperative CVP. This impairment of postoperative renal function may be caused more by an additional low arterial blood pressure than by the low intraoperative CVP itself as demonstrated by Abuelo et al. 40 Kidneys can maintain their blood flow in the mean arterial pressure (MAP) ranges between 80 and 120 mm Hg. If the MAP falls to less than 80 mm Hg, there is a significant drop in the GFR and the risk of developing an ARF increases. Further scientific investigations are required regarding the impact of intraoperative parameters such as blood loss, CVP, and MAP on postoperative ARF particularly in relation to the present risk score.
Postoperative liver failure after hepatic resection changes the hemodynamics similar to those of patients with cirrhosis or acute liver failure 14, 41 implicating a severe risk of renal failure. Increased risk for postoperative liver failure has been considered in patients with major liver resection with a consecutive small remnant liver volume, advanced age, steatosis, and cirrhosis. [42] [43] [44] [45] Postoperative liver failure is a hyperdynamic state with increased cardiac output. Example for reduced risk score: patient without preexisting cardiovascular disease (0 point), with chronic renal failure (2 points), diabetes (1 point), and ALT ϭ 60 U/L (2 points). Total of 5 points ϭ risk of ARF of 55.3%.
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Acute Renal Failure After Liver Resection It is caused by a largely increased concentration of nitric oxide (NO) in the circulation, as shown in both animal and clinical trials. 46, 47 As a result, a severe vasodilation of the splanchnic area leads to a declining central and arterial blood volume, low pulmonary capillary wedge pressure, low CVP, low systemic vascular resistance, increased carbon monoxide (CO), and reduced MAP. If the MAP drops below 80 mm Hg, the GFR will significantly decrease. 48 Based on this, similar to the mechanism of "hepatorenal syndrome," 49 intravascular hypovolemia activates the renin-angiotensin-aldosterone system and sympathetic nervous system. A subsequent vasoconstriction within the kidney lowers GFR, causing necrosis and apoptosis of tubular cells, which are sloughed, obstructing the lumen; finally, the GFR completely deteriorates. 40 Although some correlation exists between postoperative liver and kidney insufficiency, risk factors and also potential preventive strategies are different. Liver insufficiency is another end point, which needs to be evaluated with a separate prediction model. Therefore, the outcome factor liver insufficiency was not evaluated in detail in the present study. Before our scores are used widely, it is important that they are validated in other populations. It might well be that the score needs to be updated in populations where the incidence of ARF is higher or lower as it has been done for widely used risk scores such as the Framingham risk score. Also, future studies should compare the predictive performance of the full and the reduced risk scores to evaluate whether the reduced score can be used safely without much loss on information. We will certainly provide any information necessary for such out-of-population validations. Further investigations are required to evaluate the impact of possible pre-, intra-, and postoperative targets for optimizing, treating, and influencing the postoperative renal function following liver resection, and to prevent an ARF following liver surgery. It would be attractive to consider intraoperative parameters (including histologic features) to update the risk prediction in future models.
Strengths of this study include the large sample size, which allowed us to develop and validate a risk score. Validation, ie, the assessment of how close predicted risks are to observed risks (calibration), is indispensable before a risk score is used in practice. Another strength is the use of advanced statistical techniques, such as shrinkage and bootstrapping, which increase the validity and applicability of a prediction score in other settings. A limitation of this study is the fact that the patient cohort originated from one single center. We therefore encourage other groups to further validate the risk score in their population.
In conclusion, we have developed a validated risk score to accurately predict ARF in patients scheduled for liver resection. The reduced model of the score based on the 4 strongest predictors is particularly attractive for clinical practice, whereas the full score based on 7 parameters allows for more subtle risk stratification. The use of this score allows early identification of patients at high risk of ARF and may support decision-making for kidney-protective interventions before, during, and after liver resection. Prevention of ARF is important because our study has also showed that it is directly associated with mortality and the need for extended ICU and hospital care.
Discussions PROFESSOR D. JAECK (STRASBURG, FRANCE): Your large series shows that some preoperative parameters might be of interest in predicting acute renal failure (ARF) after liver resection. The study design and the statistical methods seem appropriate. However, my main concern is that the main cause of death after liver resection is liver failure, which is the most dangerous complication, often leading to death, with or without ARF. Opposed to this, postoperative ARF generally resolves when not correlated with liver failure.
Acute liver failure is mainly induced by intraoperative hemodynamic conditions, except for the risk factors you showed. Therefore, it appears that preoperative prediction of ARF might be hazardous since you do not know what will happen during the operation. Some events appearing intraoperatively may lead to ARF. Thus, it is difficult to predict, preoperatively, all the situations that can lead to postoperative ARF. Therefore, a score based on other parameters such as liver function and intraoperative hemodynamic conditions would seem more relevant to predict the prognosis of liver resection in such cases.
I have 2 questions: First, Is your next step to try to show any efficient prophylactic strategy to prevent ARF in high risk patients? Second, can postoperative mortality after liver resection be reduced by using the present predictive score? DR. S. BREITENSTEIN (ZURICH, SWITZERLAND): I agree that there might be some intraoperative parameters influencing postoperative ARF. However, potential strategies to prevent postoperative renal insufficiency already start preoperatively. For that practical reason, we aimed, with our score, to identify patients at risk at the preoperative stage, and did not include any intraoperative parameters. However, it might be an option to further develop the score in the future by adapting the score with relevant intraoperative variables in order to predict the risk of postoperative ARF even more precisely. Regarding your first question, there is indeed a possibility to prevent morbidity by using the presented score in order to identify patients at higher risk of postoperative renal insufficiency. The preoperative application of the score may allow implementing potential kidney protective strategies pre-as well as intraoperatively. We agree that as a next step we would like to perform an interventional study to evaluate the efficacy of a kidney protective strategy based on the score. Regarding your second question about mortality, we showed a very strong correlation between the occurrence of postoperative ARF and mortality in our patient collective: 0.8% versus 23%. Therefore, we can expect a dramatic improvement of the mortality rate by decreasing the occurrence of postoperative ARF. PROFESSOR J. FIGUERAS (BARCELONA, SPAIN): I am surprised that you did not include in your score what I think is most important related to renal insufficiency, that is, the type of liver resection you will perform, such as a right hepatectomy, or the underlying liver disease, for instance cirrhosis. I think for the patient with a very high score, if you perform only a small resection by laparoscopy, renal insufficiency is very unlikely.
DR. S. BREITENSTEIN (ZURICH, SWITZERLAND):
There are no doubts that the amount of tissue loss after surgery affects the risk of postoperative renal insufficiency. As mentioned in my reply to Dr. Jaeck, our score was targeted at identifying patients at risk by using pure preoperative parameters. Thus, we purposely failed to include the size of liver resection or any other intraoperative parameters such as blood loss in our score. In addition, those intraoperative parameters often cannot be predicted precisely in advance.
Regarding your next point, we agree that underlying liver diseases may influence the occurrence of postoperative renal insufficiency. We included 2 indirect markers of underlying liver diseases in the score; namely preoperative transaminase and bilirubin levels. However, we did not include histology findings as, in practice, biopsies are rarely available. PROFESSOR R. PLOEG (GRONINGEN, THE NETHERLANDS): There is another way to measure, as we do sometimes in our living donation population for kidney donors. You can use the urine glomerular test. You have the functional reserve factor of the kidneys, which will give you a very good estimate of whether the selection of your parameters is good and may even be a good measure in this elective group of patients. DR. S. BREITENSTEIN (ZURICH, SWITZERLAND): Thank you for your suggestion. Unfortunately, I am not aware of this test to measure the functional reserve of kidney function.
Annals of Surgery • Volume 250, Number 5, November 2009 Acute Renal Failure After Liver Resection PROFESSOR C. BROELSCH (ESSEN, GERMANY): We all know how important renal function is and particularly preoperative functional disturbances. This has been reflected in the MELD scoring, but I missed the liver factor in your preoperative assessment and, since you quote our paper from Saner et al, you know, that no patient will be transferred to the ICU following partial hepatectomy with imminent renal failure, at least, according to the anesthesiologist! However, renal failure starts a few days later when liver failure becomes clinically apparent. Thus, there is an association between this failing liver and renal failure. It is important to know about the intraoperative management of the patient through the operation, particularly during the dissection period. Surgeons want a very low central venous pressure, and the anesthesiologists complain about a too low fluid load and impaired renal function. It is of utmost importance to focus on the intraoperative management of the patient, irrespective of the primary INR, which responds to treatment as you wish in patients with renal impairment. DR. S. BREITENSTEIN (ZURICH, SWITZERLAND): The liver factor was not completely neglected in our score system. As mentioned in my reply to Dr. Figueras, preoperative bilirubin and transaminase levels were included in our score. We agree that liver insufficiency is sometimes associated with kidney insufficiency. In those cases, the sequence of liver insufficiency and renal insufficiency was often difficult to assess, particularly when patients were in life-threatening situations due to multiorgan failure. However, in our patient collective, ARF did not occur exclusively in association with liver insufficiency. Therefore, we think that it is appropriate to look solely at one or the other organ failure, as we did with postoperative ARF. It would be a great addition, indeed, to work on a second prediction score predicting both postoperative renal and liver failures. Regarding your third point on the relevance of intraoperative management by the anesthesiologists, we fully support this comment, although herein lies the most relevant potential for kidney protection with a focus on intraoperative fluid and blood pressure management. PROFESSOR P.-A. CLAVIEN (ZURICH, SWITZERLAND): The common theme of the discussion was to include intraoperative events such as the amount of the resected liver, blood loss, or fluid management in the score system. In practice, there are 2 relevant situations, first regarding the decision prior to surgery and second at the end of surgery, ie, at the time of delivery of the patient to the ICU. Our current study addresses only the first situation with the aim of affecting the indication of surgery, as well as intraoperative management (eg, RF vs. wedge vs. large anatomic resection and intraoperative fluid management). The second situation is, of course, very important and clearly requires the search for another scoring system. I would like, however, to point out that "preemptive" intervention prior to or during surgery is currently much more effective that any "rescue" therapy in the ICU.
